Mechanistic Insights into the Antihypertensive and Cardioprotective Actions of Corosolic Acid: A Narrative Review
Molecules · 14.08.2026 · 31 (16) · 2841
DOI: 10.3390/molecules31162841 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 14.08.2026. Verfasst von Fangying Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, Gelugor 11800 USM, Pulau Pinang, Malaysia. Hauptthemen laut MEDLINE: Triterpenes, Antihypertensive Agents, Cardiotonic Agents. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The specific mechanisms underlying the antihypertensive actions of corosolic acid (CA) have not been systematically elucidated.
Methods
Evidence was categorized according to major signaling and physiological pathways, including the renin–angiotensin system (RAS), oxidative and inflammatory responses, endothelial and smooth muscle regulation (NO/cGMP and H2S/KATP), and kinase-mediated signaling (AMPK, NF-κB, JAK/STAT, PKC).
Results
Consistent with in vitro and animal studies, CA has been reported to attenuate pro-hypertensive signaling through multiple pathways: (i) downregulating renin–angiotensin system-related cascades; (ii) reduction in reactive oxygen species and inflammatory mediators through activation of AMPK and inhibition of NF-κB and JAK/STAT pathways; (iii) improved vascular tone by enhancing NO/cGMP signaling, partly involving the H2S/KATP pathway, and inhibiting PKC. CA may indirectly contribute to blood pressure reduction by improving glucose and lipid metabolism and adipose tissue inflammation, thereby affecting metabolic risk factors. The existing evidence gaps include: lack of direct studies on voltage-gated, receptor-gated and store-regulated calcium channels; the specific effects on the isoforms of nitric oxide synthase (eNOS/iNOS/nNOS) and PKC are not known; limited human data on the antihypertensive efficacy, dose effect and safety of CA in humans are available.
Conclusions
CA may have multi-targeted blood-pressure-lowering potential. Its clinical efficacy and safety require further confirmation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, Gelugor 11800 USM, Pulau Pinang, Malaysia.
- Department of Pharmacology, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Gelugor 11800 USM, Pulau Pinang, Malaysia.
ORCID-Profile: Fangying Chen, Wan Yin Tew, Ming Thong Ong, Mun Fei Yam
Zitieren
APA
Chen, F., Tew, W. Y., Ong, M. T., & Yam, M. F. (2026). Mechanistic Insights into the Antihypertensive and Cardioprotective Actions of Corosolic Acid: A Narrative Review. Molecules, 31(16), 2841. https://doi.org/10.3390/molecules31162841
Vancouver
Chen F, Tew WY, Ong MT, Yam MF. Mechanistic Insights into the Antihypertensive and Cardioprotective Actions of Corosolic Acid: A Narrative Review. Molecules. 2026;31(16):2841. doi:10.3390/molecules31162841
BibTeX
@article{Chen2026,
author = {Chen, Fangying and Tew, Wan Yin and Ong, Ming Thong and Yam, Mun Fei},
title = {Mechanistic Insights into the Antihypertensive and Cardioprotective Actions of Corosolic Acid: A Narrative Review},
journal = {Molecules},
year = {2026},
volume = {31},
number = {16},
pages = {2841},
doi = {10.3390/molecules31162841}
}
EUVIMED